Skip to main content
. 2022 Nov 21;68(10):1376–1382. doi: 10.1590/1806-9282.20220697

Table 2. Variables.

Prescribed medications* %
Amitriptyline 95 (26.69)
Anti-inflammatory 63 (17.7)
Analgesics 22 (6.18)
Prednisone 12 (3.37)
Propranolol 11 (3.09)
Fluoxetine 8 (2.24)
Others 70 (19.66)
None 75 (21.07)
Request for laboratory tests*
No 208 (85.60)
Yes 35 (14.4)
Request for imaging tests*
No 203 (83.54)
Yes 40 (16.46)
Imaging tests requested* N 51 (100)
Computed tomography 35 (68.62)
Carotid and vertebral Doppler 5 (9.8)
Electroencephalogram (EEG) 5 (9.8)
Echocardiogram 2 (3.9)
Magnetic resonance 2 (3.9)
Computed tomography angiography 1 (1.9)
Electromyography (ENM) 1 (1.9)
Symptoms motivating teleconsultation (ICD-10)*
Headache 187 (76.95)
Epilepsy 25 (10.28)
Stroke 24 (9.87)
Others 7 (2.88)
Diagnosis after consultation*
Headache 178 (73.25)
Unspecified headache (CID R51) 126 (51.85)
Migraine (CID G43) 26 (10.70)
Tension-type headache (CID G44.2) 26 (10.70)
Epilepsy (CID G40) 18 (7.41)
Cerebrovascular disorder 16 (6.58)
Stroke, not specified as hemorrhage or infarction (CID I64) 9 (56.25)
Occlusion and stenosis of precerebral arteries (CID I65) 3 (18.75)
Transient ischemic attacks and related syndromes (CID G45) 3 (18.75)
Cerebral infarction (I63) 1 (6.25)
Syncope and collapse (CID R55) 4 (1.64)
Unspecified dementia (F03) 3 (1.23)
Others 24 (9.87)
Clinical decision*
Follow up through teleconsultation 139 (57.20)
Follow up in PHC units 53 (21.81)
Waiting list for in-person consultation with a neurologist 47 (19.34)
Immediate in-person consultation 4 (1.65)
Waiting time for the neurologist's evaluation from the request by primary care to the date of teleconsultation (days) 270 (±180)
Min-Max 5–750
*

Data are presented in absolute numbers and %;

Continuous variables without normal distribution are presented as medians and interquartile ranges.